Ligand profile
CHEMBL2178300
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL2178300- UniProt (similar protein)
P0AEK4- pchembl
- 6.960 (~109.6 nM)
- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 46.5
- −1 ≤ LogP ≤ 5 4.09
- MW ≤ 500 Da 274.3
- LogP ≤ 5 4.09
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 46.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCc1ccc(Oc2ccc(C(C)=O)cc2F)c(O)c1CCc1ccc(Oc2ccc(C(C)=O)cc2F)c(O)c1
InChI=1S/C16H15FO3/c1-3-11-4-6-16(14(19)8-11)20-15-7-5-12(10(2)18)9-13(15)17/h4-9,19H,3H2,1-2H3InChI=1S/C16H15FO3/c1-3-11-4-6-16(14(19)8-11)20-15-7-5-12(10(2)18)9-13(15)17/h4-9,19H,3H2,1-2H3
IWCDWGBUIGLXBG-UHFFFAOYSA-NIWCDWGBUIGLXBG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL2178300 →
- UniProt UniProt P0AEK4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL2178300”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 59
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).